# Montelukast as a Controller of Atopic Syndrome

> **NCT00559546** · PHASE4 · COMPLETED · sponsor: **University of Helsinki** · enrollment: 61 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis
- Allergic Conjunctivitis
- Atopic Eczema
- Asthma

## Interventions

- **DRUG:** montelukast

## Key facts

- **NCT ID:** NCT00559546
- **Lead sponsor:** University of Helsinki
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2007-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00559546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00559546, "Montelukast as a Controller of Atopic Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00559546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*